
January 30, 2025
RegMed Investors (RMi) Closing Bell: share pricing leaps and a few bounds
January 30, 2025
RegMed Investors’ (RMi) pre-open: ongoing rocky week, further erosion of pricing or some valuation bursts?
January 29, 2025
RegMed Investors (RMi) Closing Bell: a little more of the same
January 29, 2025
RegMed Investors’ (RMi) pre-open: econ day
January 28, 2025
RegMed Investors (RMi) Closing Bell: adding to investor agita
January 28, 2025
RegMed Investors’ (RMi) pre-open: The Strange Case of Dr. Jekyll and Mr. Hyde
January 27, 2025
RegMed Investors (RMi) Closing Bell: a strange turn of events
January 27, 2025
RegMedInvestors (RMi):Sage Therapeutics (SAGE) has unanimously rejected Biogen’s (BIIB) $469 M offer
January 27, 2025
RegMed Investors’ (RMi) pre-open: watchout below, AI driving down today’s market
January 24, 2025
RegMed Investors (RMi) Closing Bell: investor ambiguity points to downdraft of share pricing
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors